BIO Europe 2013 – Tying It All Together
We've returned from another successful BIO Europe conference, this time in Vienna. We regret not having much time to walk around in Vienna. However, this did not take away…
We've returned from another successful BIO Europe conference, this time in Vienna. We regret not having much time to walk around in Vienna. However, this did not take away…
Lacerta Bio is pleased to announce our participation in the 19th Annual BIO-Europe Conference in Vienna, Austria. As with last year's conference in Hamburg, this year's…
As we were making our way back home from Chicago (on delayed flights, of course), several things struck us about BIO2013. We've talked about BIO in the past.…
Now that we're back from BIO2013, we have to leave again! We'll be at ExcipientFest 2013 in Baltimore for a few days. We'll be meeting with several Exhibitors,…
Rob Wright has a really good article on preparing for BIO. In fact, it's applicable for just about any major conference or convention. You can read the entire…
As BD consultants, we attend a number of conferences, both large and small. Some have one-on-one meetings, some don't. Some are scientific conferences, while others are focused on partnering. As…
Lacerta Bio, along with approximately 10,000 other life science investors, executives, consultants, service providers, hangers-on, and many others, congregated in San Francisco for a variety of conferences, including the JP…
As we bring 2012 to a close, we're looking back at a few of the interesting events that took place. It was a challenge to whittle this down to a…
Consider the following situation: You are out-licensing an innovative asset in a niche therapeutic area It is a first-in-class molecule It has successfully demonstrated efficacy in two international Phase…
As we've done in the past, we've tabulated the countries of origin from the stack of business card collected at BIO Europe 2012. Our "rules" for this analysis are simple.…